Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by balainon Apr 30, 2021 10:22am
118 Views
Post# 33100652

RE:lmnl has been cleared since ...2019!:)

RE:lmnl has been cleared since ...2019!:)They only verified that the ppaperwork was signed properly. No investigation was done to determine I'll intent.

for the record, Galbraith left the company after being given one of the highest pay increase by a CEO that year,  a $12.6 million compensation.

That, from a company that barely makes any money and claim that they can't find any.

Also, if you follow the story a little bit, you will notice that before the takeover by Thomvest, Prometic made $47 million (CAD) in revenues that year. After they became Liminal, $6.6 million (CAD). This year, even less.

These clowns don't have a clue what they are doing. This company was taken over (stolen) for one purpose, and one purpose only. I can tell you that it is not to help patients, neither it is to make money for the shareholders...
<< Previous
Bullboard Posts
Next >>